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Introduction
It is estimated that more than two thirds of adults in the United States are overweight or obese [1] . Paralleling this rise in obesity is an increase in the incidence of chronic kidney disease (CKD) [2] [3] [4] . How obesity might increase CKD is not well understood. However, it is well accepted that increased renal lipid levels may play a pivotal role in the pathogenesis of obesity-associated nephropathy. Indeed, recent researches have demonstrated that lipid accumulation can induce functional impairment (lipotoxicity) and cell death (lipoapoptosis) [5, 6] . The mechanism(s) regulating renal lipoapoptosis have not yet been elucidated; however, it has been suggested that the abnormal lipid accumulation can induce endoplasmic reticulum (ER) stress and cellular apoptosis in several tissue types [7] [8] [9] . As endoplasmic reticulum plays a critical role in regulating metabolic homeostasis and cellular functions, perturbations of ER homeostasis in pathological conditions such as excess lipid accumulation can lead to abnormal protein translation and folding, also known as unfolded protein response, which if allowed to proceed unchecked can activate apoptotic pathway and result in cell death [8, 9] .
Acetaminophen (N-acetyl-p-aminophenol, APAP) is a widely used over-the-counter analgesic and antipyretic drug. Previous data has demonstrated that acetaminophen treatment can be effective in attenuating the increases in body fat deposition subsequent to the initiation of a high-fat diet in mice [10] [11] [12] . Whether chronic acetaminophen ingestion can function to reduce renal lipid accumulation and lipotoxicity during the development of obesity has, to our knowledge, not been investigated. To address this gap in our understanding, we examined whether acetaminophen ingestion can reduce renal lipid accumulation and lipoapoptosis in the obese Zucker rats and the potential role that ER stress may play in these processes. Our data suggest that acetaminophen administration at 30mg/kg/d can attenuate albuminuria and renal lipotoxicity in the obese Zucker rat, and that these effects are mediated, at least in part, by diminished ER-stress related signaling.
Materials and Methods

Animal study
Male obese and lean Zucker rats (3 weeks old) were purchased from Charles River Laboratories and housed two per cage under controlled temperature (~22°C) and humidity (~50%) with a 12:12 h light:dark cycle. Food and water were available ad libitum. After a week for environmental acclimation, the obese Zucker rats were randomly assigned into one of three groups (n = 6 each): obese control (OC), obese vehicle (OV, 0.073 mL DMSO/kg/d), or obese treated with acetaminophen (OT). Acetaminophen (30mg/kg/d) was dissolved in DMSO and then provided to animals via drinking water for 26 weeks as described previously [13] . Age-matched lean Zucker rats were used as controls (LC, n = 6). Animals were euthanized at 30 weeks for the collection of tissues and urine. Urine specimens were centrifuged at 2000 x g for 5 min, and the supernatant was stored at -80 o C. After removal, kidneys were snap frozen in liquid nitrogen and stored at -80 o C. All animal procedures were conducted under the Animal Use Review Board of Marshall University using the criteria outlined by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) as described in the Animal Welfare Act (PL89-544, PL91-979, and PL94-279).
Measurement of urinary albumin content
Urinary albumin concentration was determined using an enzyme immunoassay assay kit purchased from Cayman Chemical (Ann Arbor, Michigan), while urinary creatinine content was measured using a colorimetric assay kit (Cayman Chemical; Ann Arbor, Michigan). Urinary albumin was normalized to creatinine concentration and expressed as micrograms albumin per milligrams creatinine.
Detection of renal lipid accumulation
Determination of renal nuclear DNA fragmentation Apoptosis was assessed using a transferase-mediated dUTP nick-end labeling (TUNEL) kit (Roche Applied Science, Indianapolis, IN) as described previously [13, 14] . Images were captured using an Olympus (an ER stress master regulator [15] ) and CCAAT-enhancer-binding protein homologous protein (CHOP, a mediator of ER stress-induced apoptosis [16 Burlingame, CA) for 60 minutes at room temperature. Images were captured using an Olympus BX51
Immunoblotting Total protein extracts were prepared and immunoblotting was performed as previously described [13, 17, 18 CST). The secondary antibody was animal.
Statistical analysis
was determined by analysis of variance followed by the Tukey's test using SigmaStat 3.5. Differences were P
Results
Acetaminophen reduces lipid deposition in the obese kidney
Oil red O staining suggested that lipid deposition was higher in the glomeruli and tubulointerstitium of the obese control (OC) and vehicle treated (OV) animals than that observed in the lean control (LC), while these obesity-associated changes were markedly reduced in acetaminophen-treated (OT) animals ( Fig. 1) . 
Cellular Physiology and Biochemistry
Acetaminophen decreases GRP78 expression in situ in the obese kidney Elevations in ER stress have been implicated in tissues with excess lipid accumulation [8, 9] and in the pathogenesis of kidney diseases [19, 20] . To determine whether the association between changes in renal lipid deposition and acetaminophen treatment were associated with the alteration in renal ER stress, we examined the expression of the ER 15]. Compared to that observed in the lean controls, the expression control and vehicle rats and, importantly, attenuated by acetaminophen treatment ( Fig. 2A  and B) . Taken together, these data suggest that acetaminophen may suppress the activation of renal ER stress in the obese Zucker rat.
It has been suggested that increased ER stress can stimulate CHOP (also known as DNA damage-inducible transcript 3) expression, which plays an important role in inducing apoptosis [21 glomeruli and tubulointerstitium was higher in the obese control and vehicle treated rats when compared to that seen in the lean controls while it was visibly decreased following chronic low dosage acetaminophen ingestion (Fig. 3A and B) . Immunoblotting analysis (P 0.05; Fig. 3C ).
To further identify the molecular mechanism responsible for altered CHOP expression in obese kidney and the protective effect of acetaminophen, we next examined the regulation expression [22 (P 0.05; Fig.s 3D and E) . Consistent with diminished expression of CHOP, the amount of both upstream regulators were attenuated with acetaminophen treatment (P 0.05; Fig. (P = 0.28; Fig. 3D ). 
Cellular Physiology and Biochemistry urine albumin content was normalized to urine creatinine concentration and expressed as the ratio of albumin / creatinine, as suggested elsewhere [25] . Compared to the lean controls, it was markedly reduced in acetaminophen-treated animals ( Fig. 6 ; P
Discussion
Increased obesity prevalence and excessive tissue lipid accumulation in obesity have been shown to contribute to the increased kidney dysfunction and renal disease. Using the obese Zucker rat model, we demonstrate that increased renal lipid deposition was associated with increased endoplasmic reticulum stress, cellular apoptosis, and renal damage (albuminuria). In addition, our data suggest that acetaminophen ingestion (30mg/kg/d for 26 weeks) can attenuate renal lipid accumulation (Fig. 1) , renal cell apoptosis (Fig. 5B) and albuminuria (Fig. 6 ) in the young obese Zucker rat. The renoprotective effects of acetaminophen were CHOP pathway, Recent studies have demonstrated that obesity is an independent risk factor for both CKD and end-stage renal disease (ESRD) [2] [3] [4] . Indeed, it is thought that excess intracellular associated with obesity [26, 27] . Moreover, FFA overload can also stimulate the synthesis of which may be lipotoxic, especially if the LDL becomes oxidized LDL [2] . In the present study, our analysis of the oil red O staining suggested that lipids are dramatically increased in the glomeruli and moderately elevated in the tubulointerstitium of the obese animals (Fig. 1) . Oil red O is a fat-soluble diazo dye that can be used to qualitatively detect the accumulation 28]. Consistent with recent work demonstrating that acetaminophen attenuates high fat diet-induced tissue fat mass [12] , here we demonstrated that acetaminophen administration at a low dose (30 mg/kg/day) can reduce lipid deposition in the young obese Zucker kidneys. Whether these decreases in lipid deposition are solely responsible for the reduced renal apoptosis seen in the present study or if acetaminophen plays a direct role in preventing cell death is currently unclear and will require additional experimentation.
Previous data has suggested that proteinuria is often associated with increased obesity in humans and animals [29] [30] [31] we also noted that acetaminophen treatment can attenuate the extent of albuminuria (Fig. 6 ). Paralleling these decreases in urine albumin levels we also found that the number of TUNELpositive (apoptotic) cells was increased in the kidneys from both obese control and vehicle animals but diminished with acetaminophen treatment (Fig. 5B) . Taken together, these 
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry attenuate obesity-associated renal injuries.
Although the mechanisms involved in renal lipotoxicity have not been fully elucidated, accumulated experimental evidence has suggested that elevations in ER stress may be involved [32] . The ER is a principal site for protein and lipid biosynthesis, protein folding, and calcium storage and signaling. Under conditions of nutrient excess, insulin resistance and diabetes, tissue lipid metabolism can become abnormal causing elevations in ER stress [9, 33] . To examine the possible mechanism of acetaminophen with renoprotective effect, stress [15 acetaminophen treatment (Fig. 2) , suggesting that the renoprotective effect of acetaminophen may be related to its ability to attenuate obesity-associated renal ER stress. involved in FFA-induced apoptosis in human renal proximal tubular cells [8, 34] . Supporting elevations in the expression of ATF4 and CHOP in the obese kidney, and importantly, that these changes were diminished subsequent to acetaminophen treatment (Fig. 3) . Consistent phosphorylation and caspase-12 cleavage (activation) [16, 23] , were increased in the obese kidneys but diminished following acetaminophen treatment (Fig. 4 and 5) .
In summary, the data from this study demonstrate that low dose acetaminophen ingestion (30 mg/kg/d) can reduce renal lipid accumulation and the degree of cell injury observed during obesity progression in the young obese Zucker rat. This dosage, if normalized on the basis of body surface area [35] , is roughly equivalent to a human dose of approximately 4.9 mg/kg/d (or 367.5 mg/d for a 75-kg person) which suggests that it may be potentially mediated, at least in part, by suppressing ER stress and ER stress related apoptosis (Fig. 7 ).
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